First-Line Pharmacologic Treatment for Acute Anxiety in the Emergency Department
For acute anxiety presenting as agitation in the ED, use a benzodiazepine (lorazepam 2-4 mg or midazolam 5-10 mg) as first-line monotherapy. 1
Treatment Algorithm
For the Undifferentiated Agitated Patient
Benzodiazepines are the preferred first-line agents for acute anxiety manifesting as agitation in the ED setting 1. The evidence supports:
- Lorazepam 2-4 mg (IM or IV) - Level B recommendation
- Midazolam 5-10 mg (IM or IV) - Level B recommendation, with faster onset than lorazepam 2
These agents are equally effective as conventional antipsychotics (haloperidol) for controlling agitation, with multiple class II studies demonstrating comparable efficacy 1.
Alternative First-Line Options
If benzodiazepines are contraindicated or ineffective, conventional antipsychotics are acceptable alternatives:
- Droperidol 5-10 mg IM - fastest onset of sedation when rapid control is needed 1, 2
- Haloperidol 5 mg IM - well-established evidence base 1
For Cooperative Patients
Oral combination therapy with lorazepam plus risperidone is effective for agitated but cooperative patients who can accept oral medications 1.
Critical Clinical Considerations
When to Choose Benzodiazepines Over Antipsychotics
Benzodiazepines should be prioritized when:
- The etiology of agitation is uncertain (undifferentiated patient)
- Anxiety is the primary driver rather than psychosis
- There's concern about anticholinergic toxicity (sympathomimetic or anticholinergic drug ingestions can be exacerbated by antipsychotics) 1
Important Caveats
Rule out medical causes first. Before administering sedatives, ensure reversible medical causes of agitation are identified and treated 1. Look specifically for:
- Hypoglycemia
- Hypoxia
- Anticholinergic or sympathomimetic toxidromes
- Metabolic derangements
Cognitive assessment over arbitrary blood alcohol levels. The patient's cognitive abilities, rather than a specific blood alcohol concentration, should determine when to initiate psychiatric assessment 1. An alert, cooperative patient with normal vital signs and appropriate cognition can be evaluated regardless of alcohol level.
Combination Therapy
Parenteral benzodiazepine plus haloperidol may produce more rapid sedation than monotherapy in acutely agitated psychiatric patients (Level C recommendation) 1. When using combination therapy, midazolam with an antipsychotic produces faster sedation than lorazepam with an antipsychotic 2.
Common Pitfalls to Avoid
Don't delay treatment waiting for laboratory results in alert patients with normal vital signs and noncontributory examination 1
Avoid antipsychotics in anticholinergic toxicity - both conventional and atypical antipsychotics have anticholinergic properties that can worsen agitation from anticholinergic or sympathomimetic poisoning 1
Don't use ketamine as first-line - reserve ketamine (2-5 mg/kg IM) for refractory cases, as it carries higher risk of airway compromise requiring intubation 2
Droperidol concerns are overstated - despite the FDA black box warning about QT prolongation, large case series (>12,000 patients) show no documented dysrhythmic events in patients treated for agitation 1
Dosing Summary
| Agent | Dose | Route | Onset | Notes |
|---|---|---|---|---|
| Midazolam | 5-10 mg | IM/IV | Fastest | Preferred for rapid sedation [2] |
| Lorazepam | 2-4 mg | IM/IV | Moderate | Well-studied, reliable [1] |
| Droperidol | 5-10 mg | IM | Very fast | Consider if rapid sedation needed [1] |
| Haloperidol | 5 mg | IM | Moderate | Best evidence base among antipsychotics [1] |
The choice between benzodiazepines and antipsychotics should be guided by the clinical presentation, with benzodiazepines preferred for undifferentiated anxiety-driven agitation and antipsychotics reserved for known psychiatric illness where they are indicated 1.